CN114272151A - Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics - Google Patents

Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics Download PDF

Info

Publication number
CN114272151A
CN114272151A CN202210041675.5A CN202210041675A CN114272151A CN 114272151 A CN114272151 A CN 114272151A CN 202210041675 A CN202210041675 A CN 202210041675A CN 114272151 A CN114272151 A CN 114272151A
Authority
CN
China
Prior art keywords
spermidine
parts
skin
cosmetics
polyamine compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202210041675.5A
Other languages
Chinese (zh)
Inventor
林杰彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Wanqian Vermicelli Cosmetics Co ltd
Original Assignee
Guangzhou Wanqian Vermicelli Cosmetics Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Wanqian Vermicelli Cosmetics Co ltd filed Critical Guangzhou Wanqian Vermicelli Cosmetics Co ltd
Priority to CN202210041675.5A priority Critical patent/CN114272151A/en
Publication of CN114272151A publication Critical patent/CN114272151A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses an application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics, which relates to the fields of medicines and cosmetics, wherein arginine, serum protein, ergothioneine, fermented and cured placenta solution and dimethyl sulfone are contained in the spermidine polyamine compound, and the spermidine polyamine compound is applied to cosmetics and can improve the skin form and delay the aging process of the skin, the effective components directly reach dermal fibroblasts, the dermal fibroblasts penetrate and activate the skin, so that the skin becomes smoother and more elastic, the generation of active oxygen can be reduced, and cells are protected from radiation damage; the application of the compound preparation in medicines can enhance resistance, improve basal metabolism, accelerate wound healing, greatly benefit healing recovery, improve the anti-mutation and environmental injury capability of a body, control cholesterol, promote blood circulation and improve muscle strength.

Description

Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics
Technical Field
The invention relates to the field of medicines and cosmetics, in particular to an application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics.
Background
Polyamines, which means compounds containing two or more amino groups, are present in almost all cells, putrescine, spermidine and spermine are polyamines involved in a variety of known and unknown biological processes, spermidine, which is synthesized from putrescine and is used as a precursor of spermine, the intracellular level of spermidine depends on how much it is taken up extracellularly, how much it is synthesized endogenously, and how much it is catabolized, and the extracellular source of spermidine is two, one is obtained by food intake and the other is produced by intestinal microorganisms; endogenous biosynthesis of spermidine and spermine requires precursor substances such as ornithine and the like, and the gradual reaction is completed under the strict control of related enzymes, and researches prove that the spermidine can also reduce lipid accumulation in atherosclerotic plaques, the spermidine can enhance stem cell functions, promote tissue regeneration, promote hair growth, delay muscle atrophy, improve muscle regeneration and the like by improving the bioavailability of NO, the spermidine and spermine are supplemented orally, osteoporosis can be prevented by inhibiting the formation of osteoclasts (bone resorption), and researchers find that the spermidine can enhance anti-tumor immune response besides enhancing autophagy of cells, besides, the spermidine can play a role in nerve regulation and neuroprotection, improve metabolic diseases and promote nerve regeneration in vivo, Regulating the damage of the central nervous system, has the potential of diagnosing and treating human diseases, and has great and bright treatment prospect in the fields of chronic diseases, senility delaying, health improvement and the like.
The skin is the largest organ of the human body, the aging of the human body always accompanies the skin aging, if the skin is oxidized for a long time, the skin can not be well maintained, or the APSC multipotential cells of the cells in the body decline along with the aging, so that the problems of skin looseness, wrinkle growth and the like occur, and the skin shape is influenced.
At present, a lot of products for improving skin aging exist, but in some skin care products on the market, substances such as lead, mercury and the like or a corticotropin stripping promoting agent are added in a formula, so that the physiological metabolism of normal skin is damaged, the aim of improving skin aging cannot be achieved, acnes are easily caused, the skin is stimulated, skin pigment is excessively deposited, and the skin is burdened.
Disclosure of Invention
In view of the problems in the prior art, the invention discloses an application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics, which comprises the following main components in parts by weight:
Figure BDA0003470518700000021
the spermidine polyamine compound capable of stimulating the activity of the DNA protein is applied to the preparation of cosmetics, and the cosmetics capable of improving the skin shape and delaying the skin aging process can be obtained.
As a preferred technical scheme of the invention, arginine can play the roles of regulating acid, alkali, water and oil, balancing oil and fat, can directly reach fibroblasts in the dermis, has strong penetrability and bioactivity, and can enable the skin to be elastic and smoother.
The serum protein has the main effects of repairing, delaying aging, having strong water replenishing and moisturizing working capacities, converging pores, reducing the oxidation degree of skin, enabling the skin to be more white and bright, strengthening the natural barrier of the surface layer of the skin, eliminating wrinkles on the surface layer of the skin and replenishing water for the skin.
As a preferred technical scheme of the invention, the ergothioneine is a natural antioxidant, can play a protective role on cells in a human body, is an important active substance in a human body, has the functions of reducing free radicals, detoxifying, maintaining the biosynthesis of DNA, normal growth of cells, cellular immunity and other physiological functions, is a natural antioxidant which has high protection and no toxicity on cells, can chelate heavy metal ions and can prevent red cells in the human body from being damaged by the free radicals, is added into cosmetics to be used as a skin protective agent, can reduce the formation of active oxygen to the maximum extent and protect the cells from radiation damage, and can be added into certain cosmetics as a skin protective agent to be used for developing outdoor skin care products and protective cosmetics.
As a preferred technical scheme of the invention, the fermented and aged placenta solution contains substances beneficial to body functions, such as immune regulatory factor (GHF), interferon alpha and interferon beta (IFN), Erythropoietin (EPO), Nerve Growth Factor (NGF), Epidermal Growth Factor (EGF), Interleukin (IL), platelet-derived growth factor (PDGF), Transforming Growth Factor (TGF), Stem Cell Factor (SCF), insulin-like growth factor (IGF), hyaluronic acid moisturizing factor (NMF) and the like, and can strengthen skin barriers, improve dark skin color and delay skin aging.
As a preferable technical scheme of the invention, the dimethyl sulfone can enhance blood circulation, promote metabolism and has the effects of whitening and nourishing skin.
The spermidine polyamine compound capable of stimulating the activity of the DNA protein can be applied to the preparation of medicines, and can weaken the oxidation process of cells and delay the aging of the body.
The invention has the beneficial effects that: the invention provides an application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics, wherein arginine, serum protein, ergothioneine, fermented and aged placenta solution and dimethyl sulfone are contained, and when the spermidine polyamine compound is applied in the cosmetics, the spermidine polyamine compound can improve the skin form, delay the skin aging process, enable effective components to directly reach dermal fibroblasts, penetrate and activate the skin, enable the skin to be smoother and more elastic, reduce the generation of active oxygen and protect cells from radiation damage; the application of the compound preparation in medicines can enhance resistance, improve basal metabolism, accelerate wound healing, greatly benefit healing recovery, improve the anti-mutation and environmental injury capability of a body, control cholesterol, promote blood circulation and improve muscle strength.
Detailed Description
Example 1
The invention relates to an application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics, which comprises the following main components in parts by weight:
Figure BDA0003470518700000041
the spermidine polyamine compound capable of stimulating the activity of the DNA protein is applied to the preparation of cosmetics, so that the cosmetics capable of improving the skin morphology and delaying the skin aging process can be obtained, wherein the spermidine polyamine compound component can stimulate the DNA protein to enable the DNA protein to have high activity, promote the DNA synthesis process, accelerate the muscle base cell antioxidant process and delay the skin aging.
Example 2
The invention relates to an application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics, which comprises the following main components in parts by weight:
Figure BDA0003470518700000051
the spermidine polyamine compound capable of stimulating the activity of the DNA protein is applied to the preparation of cosmetics, so that the cosmetics capable of improving the skin morphology and delaying the skin aging process can be obtained, wherein the spermidine polyamine compound component can stimulate the DNA protein to enable the DNA protein to have high activity, promote the DNA synthesis process, accelerate the muscle base cell antioxidant process and delay the skin aging.
Example 3
The invention relates to an application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics, which comprises the following main components in parts by weight:
Figure BDA0003470518700000052
the spermidine polyamine compound capable of stimulating the activity of the DNA protein is applied to the preparation of cosmetics, so that the cosmetics capable of improving the skin morphology and delaying the skin aging process can be obtained, wherein the spermidine polyamine compound component can stimulate the DNA protein to enable the DNA protein to have high activity, promote the DNA repair process, accelerate the muscle base cell antioxidant process and delay the skin aging.
The fermented and cured placenta solution contains various components beneficial to human bodies, lysozyme, kininase, histaminase, oxytocin and the like, and also contains erythropoietin, phospholipid, various polysaccharides and various antibodies, so that the body resistance can be increased, and the fermented and cured placenta solution contains trophoblast protein, has biological activity, can resist bacteria, diminish inflammation, inhibit melanin generation, improve the conditions of rough and loose skin, wrinkle increase and the like, can remove freckles, whiten skin, prevent the skin tension from being reduced, moisten and fine the skin, and improve and maintain the elasticity of muscles.
Ergothioneine is an important active substance in a body, is a natural antioxidant, is safe and non-toxic, has the main functions of whitening and removing freckles, serves as an antioxidant of skin cells, can improve the activity of cortical cells when being externally used on the skin due to the coenzyme-like property, has the function of preventing skin aging, can inhibit the activity of melanocytes and reduce the generation of melanin, has a synergistic effect when being used together with placenta extract of a human body, has strong oxidation resistance, can improve the skin brightening effect, remarkably slows down the skin aging phenomenon, and has good synergistic whitening and anti-aging strengthening effects.
The spermidine polyamine compound capable of stimulating the activity of the DNA protein is applied to the preparation of medicines, so that the medicines capable of improving immunity and enhancing resistance can be obtained, wherein the dimethyl sulfone can dredge blood vessels, remove gastrointestinal toxins and the like, the fermented and aged placenta solution can improve basic metabolism, activate functions of cells, organs or visceral organs, accelerate wound healing, greatly benefit healing recovery, improve the anti-mutation and environmental injury capacities of bodies, and the arginine is beneficial to correcting the acid-base balance during hepatic encephalopathy, can control cholesterol, promote blood circulation and improve muscle strength.
Components not described in detail herein are prior art.
Although the present invention has been described in detail with reference to the specific embodiments, the present invention is not limited to the above embodiments, and various changes and modifications without inventive changes may be made within the knowledge of those skilled in the art without departing from the spirit of the present invention.

Claims (6)

1. The application of spermidine polyamine compound capable of stimulating the activity of DNA protein in medicines and cosmetics is characterized in that the spermidine polyamine compound comprises the following main components in parts by weight: 30-40 parts of arginine, 60-70 parts of serum protein, 50-60 parts of ergothioneine, 10-20 parts of fermented and aged placenta solution and 20-30 parts of dimethyl sulfone.
2. The use of a spermidine polyamine compound that stimulates DNA protein activity in pharmaceuticals and cosmetics according to claim 1 wherein: consists of 30 parts of arginine, 60 parts of serum protein, 50 parts of ergothioneine, 10 parts of fermented and aged placenta solution and 20 parts of dimethyl sulfone.
3. The use of a spermidine polyamine compound that stimulates DNA protein activity in pharmaceuticals and cosmetics according to claim 1 wherein: the placenta hominis extract is prepared from 35 parts of arginine, 65 parts of serum protein, 55 parts of ergothioneine, 15 parts of fermented and aged placenta hominis solution and 25 parts of dimethyl sulfone.
4. The use of a spermidine polyamine compound that stimulates DNA protein activity in pharmaceuticals and cosmetics according to claim 1 wherein: consists of 40 parts of arginine, 70 parts of serum protein, 60 parts of ergothioneine, 20 parts of fermented and aged placenta solution and 30 parts of dimethyl sulfone.
5. Use of a spermidine polyamine compound that stimulates the activity of DNA proteins according to claims 1-4 in medicine.
6. Use of a spermidine polyamine compound that stimulates the activity of DNA proteins according to claims 1-4 in cosmetics.
CN202210041675.5A 2022-01-14 2022-01-14 Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics Withdrawn CN114272151A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210041675.5A CN114272151A (en) 2022-01-14 2022-01-14 Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210041675.5A CN114272151A (en) 2022-01-14 2022-01-14 Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics

Publications (1)

Publication Number Publication Date
CN114272151A true CN114272151A (en) 2022-04-05

Family

ID=80880918

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210041675.5A Withdrawn CN114272151A (en) 2022-01-14 2022-01-14 Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics

Country Status (1)

Country Link
CN (1) CN114272151A (en)

Similar Documents

Publication Publication Date Title
JP2649531B2 (en) Products consisting of organosilicon compounds combined with cosmetically active substances
CN109077960A (en) A kind of anti-ageing lightening compositions of white birch myron
EP1493431A3 (en) Use of an extract of bauhinia for the preparation of pharmaceutical and cosmetic compositions
CN108430587A (en) Include the personal care composition of taurine, arginine, glycine
WO2013190567A4 (en) Composition and method for an intradermal hair growth solution
CN113425639B (en) Antioxidant composition, application thereof and product
JP2008100943A (en) External preparation for skin having action to promote secretion of insulin-like growth factor 1
CN114272151A (en) Application of spermidine polyamine compound capable of stimulating activity of DNA protein in medicines and cosmetics
KR101305274B1 (en) Composition for improving collagen synthesis
JPH11100320A (en) Preparation for external use for skin
CN111493243A (en) Beverage for assisting whitening, brightening skin color, resisting saccharification and supplementing collagen and preparation method thereof
JPH0465047B2 (en)
US20200164037A1 (en) Dermocosmetic composition containing synthetic platelet-like molecules to treat skin aging and stimulate hair growth
CN111617025B (en) Fermentation product cosmetic for whitening, removing freckles and resisting saccharification
CN111870558B (en) Composition for inhibiting hyaluronidase activity and skin care product
CN113633585B (en) External hair care composition and preparation with effects of preventing alopecia, promoting hair growth and blackening hair and preparation method thereof
JP2002284668A (en) Preventive and therapeutic agent against darkening
CN113244160A (en) Multi-effect skin care injection and preparation method thereof
CN113081926A (en) Nourishing and skin beautifying cream and preparation and use methods thereof
EP3756477A1 (en) Nano collagen peptide chelate mineral and method for preparing the same
CN111840127A (en) Free radical scavenger with anti-aging and sugar-resistant functions and preparation method thereof
RU2210359C1 (en) Cosmetic agent
Hirobe Iron and skin health: iron stimulates skin function
CN111685246A (en) Beverage containing rose essence and rose fragrance and preparation method thereof
EP3666249B1 (en) Complexes of organic silicon compounds with boron citrate and dimethylethanolamine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20220405

WW01 Invention patent application withdrawn after publication